Global crisis to raise generics drug demand: Teva CEO

TEL AVIV (Reuters) - The global economic slowdown will boost demand for generic medicines, the head of Teva Pharmaceutical Industries (TEVA.O) (TEVA.TA) said on Tuesday.

"Generics are a solution for governments wanting to cut costs during the global crisis," Shlomo Yanai, president and chief executive of Teva told a news conference. "We believe demand for generic drugs will rise."

Teva is the world''s largest generic drugmaker.

(Reporting by Tova Cohen, Editing by Steven Scheer)